vadimezan has been researched along with Hepatitis B, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, TM; Chang, J; Guo, F; Guo, JT; Han, Y; Jiang, JD; Liu, F; Wang, J; Wei, L; Xu, C; Zhao, X | 1 |
1 other study(ies) available for vadimezan and Hepatitis B, Chronic
| Article | Year |
|---|---|
STING agonists induce an innate antiviral immune response against hepatitis B virus.
Topics: Animals; Antiviral Agents; Cell Line; Hepatitis B virus; Hepatitis B, Chronic; Immunity, Innate; Membrane Proteins; Mice; Virus Replication; Xanthones | 2015 |